Proactive Investors - Run By Investors For Investors

Cosmos Holdings transfers its interest in Marathon Global to a cannabis investment firm

As part of the deal, Cosmos will still distribute Marathon Global's line of medical cannabis products
a vial of medical marijuana
Cosmos has a trans-European network of more than 160 clients and vendors

Pharmaceutical wholesaler Cosmos Holdings Inc (OTCQB:COSM) announced Tuesday that it has transferred its interest in the medical cannabis group Marathon Global to the investment firm Kaneh Bosm BioTechnology Inc (CSE:KBB).

Under the terms of the share exchange agreement, Cosmos has swapped its undisclosed stake in Marathon Global for 10 million shares of Kaneh Bosm, a Canadian-listed investment firm that specializes in the acquisition of marijuana projects and cannabis-related companies.

Cosmos will control about 7% of the 141,219,108 shares of stock that Kaneh Bosm issued.

As part of the deal, Cosmos will still distribute Marathon Global’s line of medical cannabis products as well as its cannabis derivatives to its clients in countries where medical cannabis is approved for sale.

BIG PICTURE: Cosmos Holdings focuses on Europe as it expands its global wholesale pharmaceutical business

“I am pleased to announce this agreement will provide Cosmos with additional product lines, all of which we anticipate will increase revenues and profitability on a global scale,” said Cosmos CEO Gregory Siokas in a statement.

Based in Chicago, Cosmos Holdings is a pharmaceutical wholesaler with offices and warehouses in Thessaloniki, Greece and Harlow, UK. The company has a trans-European network of over 160 clients and vendors and conducts business in Germany, the United Kingdom, Ireland, the United Arab Emirates, Denmark, Italy, France, Singapore, Spain, Lebanon, Skopje, Jordan, Sweden, Poland, Netherlands, and Greece.

Kaneh Bosm specializes in the acquisition of marijuana projects and cannabis-related companies while Marathon Global is a private Canadian company specializing in the supply of cannabis.

The use of cannabis for medical purposes is slowly being accepted by governments, with countries such as the Netherlands, Italy and Germany taking the lead with early adoption of regulations. Canada recently legalized the recreational use of marijuana.

Cosmos Holdings shares held steady at US$6.70 in morning trade.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full COSM profile View Profile

Cosmos Holdings Inc Timeline

Article
July 03 2018

Related Articles

Oncoprex
October 18 2018
The biotech was founded by an investment group led by scientists and driven by a no-nonsense CEO whose stake is more than just business as usual
Cancer cells
June 27 2018
The Nottingham-based privately-owned company has made an impressive fist of developing the OMIS (Opto-magnetic Imaging Spectroscopy) cancer detection system
woman at a microscope
August 02 2018
Currently undergoing phase III clinical trials, AP101 is being developed to treat Epidermolysis Bullosa, a condition which occurs prominently in children and makes skin fragile to even the faintest touch

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use